Reis Anne Sulivan Lopes da Silva, Furtado Guilherme Eustáquio, Menuchi Marcos Rodrigo Trindade Pinheiro, Borges Grasiely Faccin
Postgraduate Program in Physical Education, The State University of Santa Cruz (PPGEF/UESB/UESC), Ilhéus 45650-000, BA, Brazil.
Polytechnic Institute of Coimbra, Applied Research Institute, Rua da Misericórdia, Lagar dos Cortiços-S. Martinho do Bispo, 3045-093 Coimbra, Portugal.
Healthcare (Basel). 2024 May 7;12(10):954. doi: 10.3390/healthcare12100954.
This study evaluated the methodological quality of published systematic reviews on randomized and non-randomized clinical trials to synthesize evidence on the association between IL-6, immunosenescence, and aerobic and/or resistance exercise.
The Preferred Reporting Items for Overviews of Systematic Reviews (PRIO-harms) guideline was used, with registration number CRD42022346142-PROSPERO. Relevant databases such as Cochrane Library, PubMed, Web of Science, Scopus, and Google Scholar were searched using English Medical Subject Headings terms. Inclusion criteria were systematic reviews analyzing aerobic exercise, resistance exercise, or a combination of both and assessing IL-6 as a biomarker of cellular immunosenescence in humans. The Measurement Tool to Assess Systematic Reviews 2 (AMSTAR-2) was employed.
Out of 742 identified articles, 18 were eligible, and 13 were selected for analysis. Sample sizes ranged from 249 to 1421 participants, mostly female, with ages ranging from 17 to 95 years. Aerobic exercise was the most studied type (46.15%), followed by combined exercise (38.46%) and resistance exercise (15.38%). Aerobic exercise showed a statistically significant reduction in IL-6, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) levels. Among the 13 reviews analyzed using AMSTAR-2, 8 were rated as critically low quality, and 5 were classified as low quality.
Aerobic exercise has anti-inflammatory properties and the potential to modulate IL-6, CRP, and TNF-α levels in immunosenescence. However, the limited methodological quality of the analyzed systematic reviews highlights the urgent need for robust, high-quality studies to improve access to information and facilitate evidence-based decision-making in healthcare.
本研究评估了已发表的关于随机和非随机临床试验的系统评价的方法学质量,以综合关于白细胞介素-6(IL-6)、免疫衰老与有氧和/或抗阻运动之间关联的证据。
采用系统评价概述的首选报告项目(PRIO-harms)指南,注册号为CRD42022346142 - PROSPERO。使用英文医学主题词检索Cochrane图书馆、PubMed、科学网、Scopus和谷歌学术等相关数据库。纳入标准为分析有氧运动、抗阻运动或两者结合并评估IL-6作为人类细胞免疫衰老生物标志物的系统评价。采用评估系统评价的测量工具2(AMSTAR-2)。
在742篇已识别的文章中,18篇符合条件,13篇被选入分析。样本量从249名至1421名参与者不等,大多数为女性,年龄从17岁至95岁。有氧运动是研究最多的类型(46.15%),其次是联合运动(38.46%)和抗阻运动(15.38%)。有氧运动显示IL-6、C反应蛋白(CRP)和肿瘤坏死因子-α(TNF-α)水平有统计学显著降低。在使用AMSTAR-2分析的13篇综述中,8篇被评为极低质量,5篇被归类为低质量。
有氧运动具有抗炎特性,并有调节免疫衰老中IL-6、CRP和TNF-α水平的潜力。然而,所分析的系统评价方法学质量有限,凸显了迫切需要开展有力的高质量研究,以改善信息获取并促进医疗保健中的循证决策。